Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

Meet Our Section Editor promotion: free to download

Pp: 853-853
S.K. Srivastava
DOI: 10.2174/156800961911191111145625

Reprints Eprints

The Role of Shcbp1 in Signaling and Disease

Pp: 854-862
Geng-Yuan Zhang, Zhi-Jian Ma, Long Wang, Ruo-Fei Sun, Xiang-Yan Jiang, Xu-Juan Yang, Bo Long, Hui-Li Ye, Shu-Ze Zhang, Ze-Yuan Yu, Wen-Gui Shi and Zuo-Yi Jiao*
DOI: 10.2174/1568009619666190620114928

Reprints Eprints

Study of Serum Soluble Programmed Death Ligand 1 as a Prognostic Factor in Hepatocellular Carcinoma in Egyptian Patients

Pp: 896-905
Fatma El-Gebaly , Sabry Abou-saif , Mahmoud Elkadeem, Amal Helmy, Sherief Abd-Elsalam *, Mohamed Yousef, Reham Abdelkader Elkhouly, Ibrahim Fathi Amer and Taher El-Demerdash
DOI: 10.2174/1568009619666190718141647

Reprints Eprints

Differential Expression of TOM34, AL1A1, PADI2 and KLRBA in NNK Induced Lung Cancer in Wistar Rats and their Implications

Pp: 919-929
Mohammad Asad, Saima Wajid, Deepshikha Pande Katare, Ruchi Jakhmola Mani and Swatantra Kumar Jain*
DOI: 10.2174/1871525717666190717162646

Reprints Eprints

Acknowledgements to Reviewers promotion: free to download

Pp: 930-930

DOI: 10.2174/156800961911191111153648

Reprints Eprints